Regardez la pièce de trac, l'offre n'est que de 21 millions ici, le point bas est de bons bénéfices à long terme, le biop est de la même manière

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.